One of the key events in tumor initiation in mouse skin is mutational activation of the H-ras gene. Papillomas induced by the most carcinogenic environmental polycyclic aromatic hydrocarbon (PAH), dibenzo [a,l]pyrene (DB[a,l]P), in SENCAR mouse skin contain a speci®c H-ras codon 61 (CAA?CTA) mutation. We describe here detection of these mutations in preneoplastic skin by measuring the frequency of an induced XbaI RFLP, created by the mutation. Development of the PCR-XbaI RFLP method, sensitive enough to detect 1 codon 61 mutant allele among 10 000 wild-type genes, is described. The results indicate that codon 61 mutations are induced 1 day (0.1%) after DB[a,l]P treatment on mouse skin, reach a high value (5%) by day 3, rapidly decline between days 7 ± 9 and increase again during the clonal expansion of pre-papillomas into tumors. The detection of codon 61 mutations 1 day after DB[a,l]P exposure suggests that mutations occurred by pre-replication misrepair.
One of the key events in tumor initiation in mouse skin is mutational activation of the H-ras gene. Papillomas induced by the most carcinogenic environmental polycyclic aromatic hydrocarbon (PAH), dibenzo [a,l] pyrene (DB[a,l]P), in SENCAR mouse skin contain a speci®c H-ras codon 61 (CAA?CTA) mutation. We describe here detection of these mutations in preneoplastic skin by measuring the frequency of an induced XbaI RFLP, created by the mutation. Development of the PCR-XbaI RFLP method, sensitive enough to detect 1 codon 61 mutant allele among 10 000 wild-type genes, is described. The results indicate that codon 61 mutations are induced 1 day (0.1%) after DB[a,l]P treatment on mouse skin, reach a high value (5%) by day 3, rapidly decline between days 7 ± 9 and increase again during the clonal expansion of pre-papillomas into tumors. The detection of codon 61 mutations 1 day after DB[a,l]P exposure suggests that mutations occurred by pre-replication misrepair.
Keywords: dibenzo [a,l] pyrene; SENCAR mouse; quantitative PCR; gleaning eciency; in vivo mutation; DNA repair Dibenzo [a,l] pyrene (DB[a,l]P) induces in SENCAR mouse skin a high yield of papillomas which contain a speci®c Harvey-ras codon 61 (CAA?CTA) mutation (Chakravarti et al., 1995) . These mutations are expected to be acquired in early preneoplasia, during tumor initiation (Kemp et al., 1994) , when speci®c mutations would occur at sites of DB[a,l]P-DNA damage, such as bulky stable and depurinating adducts. DNA synthesis is strongly inhibited by both bulky stable adducts and depurinated (abasic) sites; however, translesional replication in vitro indicates them to be weakly premutagenic (Rodriguez and Loechler, 1993; Drouin and Loechler, 1993) . Since translesional replication is thought to be the mechanism of mutagenesis, rare mutations are expected in preneoplasia (Nelson et al., 1992) , although this is not established. For example, mathematical modeling of 7,12-dimethylbenz [a] anthracene (DMBA)-induced tumorigenesis predicts that approximately 1% of skin cells may become initiated (Kopp-Schneider and Portier, 1992) .
Mutations may also occur by misrepair of DNA lesions (Schaaper et al., 1987) . The developmental pro®le of preneoplastic oncogenic mutations may help us understand the mechanism of mutagenesis. For example, when H-ras mutations were detected 7 days after DMBA treatment on CD-1 mouse skin, it was suggested that two rounds of cell division are involved in mutagenesis (Nelson et al., 1992; Finch et al., 1996) . We report the development of a PCR-based method to measure the frequency of codon 61-induced XbaI RFLP in genomic DNA. Using this method, we found that one day after SENCAR mouse skin was treated with DB[a,l]P, 0.1% of the H-ras genes contained codon 61 mutations. This rose to 5% by day 3. The high level of codon 61 mutations in day 3 skin DNA was con®rmed by cloning H-ras PCR product, isolating subclones and performing sequence analysis.
Results and Discussion

PCR polymerase-induced artifact codon 61 mutations
Since PCR polymerases often induce artifact mutions, we tested AmpliTaq, Tth and Pfu polymerases and some combinations (16 : 1 AmpliTaq+Pfu, 8:1 Tth+Vent) for generation of artifact codon 61 mutations using a wild-type H-ras recombinant plasmid (pWT). The induction of an XbaI RFLP in the PCR products was determined by PhosphorImager densitometry of the region comigrating with XbaI RFLP bands (400 and 150 bps) in H-ras PCR product from a plasmid (pMUTX) containing a codon 61 mutation (Figures 1 and 2) . AmpliTaq (0.006% artifact product) and Pfu (0.004%) generated relatively more error-free codon 61 products than Tth (0.017%). Combination of two enzymes yielded less artifact product than the individual enzymes, with 8 : 1 Tth+Vent (0.0009%) being better than 16 : 1 AmpliTaq+Pfu (0.006%).
To determine the extent of XbaI restrictability of mutated codon 61, H-ras PCR products of pMUTX and another plasmid, containing an additional ectopic XbaI site (at codon 35/36), pMUT2X (a laboratory construct), were compared. Comparison of PhosphorImager pixel counts of pMUTX bands (400 and 150 bps) with those from pMUT2X (295, 150 and 105 bps) indicated that XbaI digestion was less ecient at codon 35/36 (79%) than at codon 61 (92%) (Figure 2 ), suggesting that the codon 61 microenvironment is conducive to XbaI digestion. A spurious band of approximately 450 bp (F) was also noted in every PCR ampli®cation reaction and was weakest with 8 : 1 Tth+Vent polymerase (Figure 2) . PCR products were digested with PleI to analyse its H-ras restriction pro®le, with a view to using the enzyme for determining the RFLP induction at codon 13 by GGC?GTC mutation. Unexpectedly, PleI recognized an uncharacterized DNA sequence in wild-type H-ras DNA, generating 2 bands of approximately 310 bp and 240 bp in length (Figure 2 ). Sequence analysis of PleI-digested pWT DNA indicated that the incision occurred between 5 ± 11 nt upstream of exon 2 (data not shown). We have used PleI digestibility to con®rm that PCR products from DB[a,l]P-treated skin DNA contain the H-ras sequence in them.
Optimization of H-ras ampli®cation
Bypass of pause sites. To minimize any spurious bands originating from premature termination, we studied the H-ras template by linear ampli®cation. Using radiolabeled primer MRFD and 0 ± 5% formamide, 0.5 mg BamHI-digested pWT was extended either at 728C or at 808C. Use of 808C extension temperature was more eective in enhancing the yield of the intended 554 nt single-stranded product than exogenously added formamide, whereas formamide was more eective in minimizing premature terminations ( Figure 3) . The results suggest that formamide may destabilize template secondary structure regions to lower failure synthesis, but does not otherwise enhance the yield. The use of 808C extension was comparatively more eective in increasing the ampli®cation yield than 728C extension, but did not eliminate the prematurely terminated products (Figure 3 ). H-ras PCR amplification reactions were, therefore, extended at 808C with 5% formamide.
Optimization of priming eciency. Incorporation of a few initial cycles of low-temperature annealing was previously shown to enhance primer extension efficiency (Rychlik, 1995) . The eect of inclusion of`cold' (48C annealing) cycles into`hot' (558C annealing) cycles was tested as: 0+25, 3+22, 5+20, 10+15, 15+10, 25+0 (cold+hot) in the ampli®cation of EcoRI-digested pWT DNA with primers MRF and MRR. The results indicated that maximal yield of the 550 bp H-ras product was obtained when the protocol contained ®ve cold and 20 hot cycles (data not shown). The use of 5+20 cycles gave marginally more of the 550 bp PCR product than was obtained from 3+22 cycles (Figure 4 ). The inclusion of formamide (0 ± 5%), which improves ampli®cation eciency (Sarkar et al., 1990) , in the 5+20 cycles did not further enhance the yield ( Figure 4 ). Since addition of formamide does not increase priming eciency (Rychlik, 1995) , our data (Figures 3 and 4) suggest that formamide might be eective in destabilizing template secondary structure regions that block DNA chain extension. Therefore, 5+20 (cold+hot) annealing cycles were used in the PCR protocol.
Optimization of gleaning eciency.`Gleaning efficiency' can be described as the ability of the PCR process to maintain in the PCR product the relative (Figure 5d ). The top arrow in Figure 5c and d points to the XbaI-undigestible fraction (550 bp) and the middle and bottom arrows point to the XbaI-digested fractions (400 and 150 bps). The results of PhosphorImager quantitation of the RFLP bands from three independent experiments were averaged and the data plotted as RFLP fraction vs mutant allele fraction ( Figure 5a ). The results indicate that as mutant dilution was increased, PCR gleaned the supplied proportions of wild-type and mutant templates with decreased efficiency. A replot of the data (in logarithmic scale), shows the gleaning eciency to be biphasic (Figure 5b ). The gleaning phases obtained from plasmid mixtures were 1 : 1 to 100 : 1 (phase 1) and 100 : 1 to 100 000 : 1 (phase 2), and from genomic DNA mixtures, 6 : 1 to 50 : 1 (phase 1) and 50 : 1 to 100 000 : 1 (phase 2). Thus, gleaning followed the relative amounts of template molecules more closely in the ®rst phase than in the second phase; yet detection of the rare allele was possible in both phases. Results obtained from independent experiments with genomic DNA mixtures indicated that despite Figure 7 ). Although the PCR-RFLP protocol exhibited 10 75 as the limit of mutant allele detection, this was also the background (noise) level. Consistent quantitation of mutations was possible to 10 74 . It is plausible that a threshold level of product molecules generated in the initial cycles of amplification may begin to compete with the supplied template for template activity, thus marking the two phases. The biphasic curve from genomic DNA was markedly less steep ( Figure 5 ), which might have resulted from the presence of heterologous templates in genomic DNA. A somewhat similar protocol was previously employed to quantitate these mutations in cell culture (Nakazawa et al., 1992) . In these experiments, 10 mg of genomic DNA (6610 6 single copy gene molecules) was ampli®ed in 100 ml reactions with a detection eciency of 10 76 . In eect, excess template was used for PCR ampli®cation to enhance gleaning eciency. Under our reaction conditions (20 ml reactions), however, both 10 mg and 2 mg DNA (proportional dilution) ampli®ed poorly (data not shown). In addition, the use of low initial primer concentrations described in`booster PCR' (Ruano et al., 1989) did not show any further increases in gleaning eciency (data not shown). Gleaning was previously reported to be more faithful to template proportions by employing a 2-round protocol, in which a nested 2nd round ampli®cation was conducted with tenfold lower primer concentration (Nakajima et al., 1993) . The use of 2-round PCR ± RFLP protocols yielded non-biphasic, straight-line gleaning curves (Chakravarti et al., 1996; Finch et al., 1996) , but our experiments with a 2-round protocol in mouse skin resulted in highly variable RFLP quantitation. The variability may suggest a focal distribution of codon 61 mutated cells; however, possible experimental artifacts would complicate interpretation of the results. Such variability has also been observed in DMBA-treated mouse skin (Finch et al., 1996) . Despite yielding a biphasic standard curve, the one-round ampli®cation and labeling protocol described here was adequate for the analysis and showed minimal variability of RFLP results. This protocol, therefore, represents a signi®cant improvement in quantitative PCR technology.
Analysis of uninitiated and TPA-treated mouse skin for codon 61 mutations
A small population of cells in target tissues is thought to pre-exist with oncogenic mutations (Cha et al., 1994) .
DNA samples (600 ng) from uninitiated, acetone-treated skin (PJ13) or tumor promoter (12-O-tetradecanoylphorbol-13-acetate, TPA)-treated skin (VE 11 ± 21) were tested by PCR-RFLP for the presence of codon 61 mutations ( Figure 6 ). TPA induces cytologically evident, reactional hyperplasia by 12 h (VE11 and VE12), that increases cell population by tenfold between 24 h (VE14 and VE15) and 48 h (VE21) (Aldaz et al., 1985; Casale et al., 1997) . As controls, 6 : 1 and 100 : 1 mixtures of wild type (ZZ11) with tumor DNA (FI2) were included in the analysis. The undigested 550 bp and XbaI-digested 400 bp and 150 bp bands are indicated by the top, middle and bottom arrows in Figure 6 . The results indicate that acetone-treated or TPA-treated skin contained background levels of codon 61 mutations ZZ11  WD22  JB44  JB33  JB25  WD51  WD52  ZD21  ZE21  A42  Allele Diln   0d  1d  3d  5d  6d  9d  21d  35d  Tumor Preneoplastic Skin a b Figure 7 Codon 61 RFLP analysis for the presence of preneoplastic mutations in 200 nmol DB[a,l]P-treated mouse skin. P (a) shows a typical RFLP gel and b shows a plot of the mutation frequency vs days after the DB[a,l]P treatment on the skin. Mixtures of tumor (FI2) and normal skin DNA (ZZ11) were included as control (allele dilution), as described in text. The top arrow indicates the XbaI-undigested (550 bp) fraction and the middle (400 bp) and bottom (150 bp) arrows indicate the XbaI restriction fragments in a (f MUT =0.0270.05), indistinguishable from a mutation frequency (MF) of 10 75 (Figure 5d ), suggesting that any possible pre-existing mutations were present at background frequencies or not at all.
Analysis of DB[a,l]P-treated preneoplastic skin and tumors for codon 61 mutations
Mouse skin was initiated once at day 0 with 200 nmol DB[a,l]P (0 ± 7 day samples). Starting at day 7, the skin was promoted twice weekly with TPA (days 9, 21 and 35 and tumor samples). The H-ras codon 61 mutation was analysed in skin DNA harvested at 0, 1, 3, 5, 6, 9, 21 and 35 days and in papillomas (FI2 and A42) harvested at 63 days. A representative PCR ± XbaI RFLP analysis of preneoplastic skin and tumor DNA (Figure 7a ) and a plot of mutant allele frequency vs days after application of the initiating dose (Figure 7b ) are shown. The analysis was authenticated by cleaving the 400 bp band by XbaI ± PleI double-digestion in a duplicate gel (data not shown). Codon 61 mutations were observed by day 1 (0.1%), increased to 5% by day 3, persisted at this level till day 5, and rapidly decreased to background level (0.0001%) between days 7 ± 9. The background level of mutations was maintained through day 21. By day 35, concurrently with the appearance and clonal expansion of prepapillomas, codon 61 mutation frequency appeared to increase towards tumor level (day 63). We also found evidence for unequal H-ras codon 61 mutational content in papillomas by conducting PCR-RFLP analysis on eight papillomas which contained between 14 ± 47% codon 61 mutations (data not shown). Data from tumor FI2, containing 14%, and tumor A42, containing 47% codon 61 mutation, are shown (Figure 7a ). The XbaI digestibility (d) of H-ras PCR products in control mixtures of genomic DNA varied from 85 ± 95% between experiments, which altered the d value between 1.15 to 1.05, respectively, and is a possible source of error in quantitating mutation frequency. Between these extremes, the fraction of mutations (f MUT ) values from preneoplastic skin DNA vary by approximately +10%, which does not signi®cantly alter our results.
Analysis of mutation spectra in preneoplastic skin
The high levels of preneoplastic mutations indicated by the PCR-RFLP experiment allowed us to conduct a con®rmatory analysis by directly cloning day 3 H-ras PCR product in pUC18, isolating subclones and performing sequence analysis of individual inserts as described (Materials and methods). Results are shown as a mutation spectrum obtained from sequencing 34 recombinant plasmids, 13 of which contained a total of 15 mutations, including ®ve codon 61 (A to T) transversions (Figure 8 top) . The frequency of codon 61 mutations at day 3, as obtained from sequence analysis, was higher (14.7%) than from PCR-RFLP quantitation (5%). The smaller sample size in the sequencing experiment and passage through bacteria may have contributed to the dierence.
We sought to determine whether the day 3 codon 61 mutations were translesional PCR artifacts or not. PCR artifact mutation spectra were generated by treating pWT with anti-DB[a,l]P-11,12-diol-13,14-epoxide (anti-DB[a,l]PDE) (NCI Chemical Carcinogen Repository, Bethesda, MD) and amplifying the damaged DNA with either 8 : 1 Tth+Vent DNA polymerase or Tth DNA polymerase (Figure 8 middle and bottom) . Like its parent PAH, DB[a,l]P, anti-DB[a,l]PDE also induces a high frequency of H-ras codon 61 mutation-bearing mouse skin papillomas (Chakravarti, et al., 1995) . Both artifact spectra were generally dierent from the day 3 spectrum and showed no codon 61 mutations (nt. 391), suggesting that day 3 mutations resulted from metabolic events in vivo. The dierences between the two artifact spectra might have resulted from the presence (8 : 1 Tth+Vent DNA polymerase) or absence (Tth DNA polymerase) of proofreading activity. Proofreading activity in a DNA polymerase has been noted to be bene®cial in translesional synthesis, such as in 3'-5' exo 7 Klenow compared to its exo + counterpart (Chary and Lloyd, 1995) .
Observation of codon 61 mutations as early as 1 day after DB[a,l]P treatment suggests that mutagenesis occurred by pre-replication repair. This conclusion is reached on the basis of experiments with DMBA which suggest that the ®rst cellular responses include a dosedependent block of DNA replication to 10% of normal (or 0.6% of total cell population) for up to 2 days (Slaga et al., 1974) and induction of unscheduled DNA synthesis (excision repair) 24 h after exposure (Sawyer et al., 1988; Gill et al., 1991) . The pattern of DB[a,l]Pinduced inhibition of DNA synthesis or induction of excision repair in mouse skin has not yet been studied. Since both DMBA and DB[a,l]P generate depurinating DNA adducts as their major DNA lesion (Devanesan et al., 1993; Li et al., 1997) , DB[a,l]P would be expected to modulate DNA synthesis and repair activities similarly to DMBA. Excision repair-induced mutagenesis has been reported in E. coli to make C?T mutations when repairing U.V. damage by the uvrABC pathway (Schaaper et al., 1987) and G?C mutations in g-irradiated plasmids containing lacZ or lacI genes (cited as Retel's work by Lehman et al., 1996) . Finally, the PCR ampli®cation described here would not discriminate between possible misrepair-induced single-strand mutations that generate mismatched heteroduplexes and ®xed allelic mutations expected from two rounds of replication (Nelson et al., 1992; Chakravarti et al., 1995) . We are currently examining the molecular nature of these mutations in preneoplastic skin.
Materials and methods
DB[a,l]P treatment of animals and isolation of DNA
Dorsal skin of 8-week-old female SENCAR mice (NCI, Frederick, MD) was shaved and treated with 200 nmol of DB[a,l]P (synthesized in our laboratory) in 100 ml acetone. At indicated times, animals were sacri®ced, dorsal skin harvested, frozen with liquid N 2 and stored at 7808C. DNA was isolated from 12 sq cm skin sections and papillomas as described before (Chakravarti et al., 1995) .
Construction of plasmids containing wild-type and mutated H-ras DNA
A 550 bp H-ras exon 1 ± 2 region was PCR ampli®ed from DB[a,l]P-induced papilloma DNA with primers MRF and MRR (Figure 1) (Chakravarti et al., 1995) , and cloned into pBluescript II KS (7) SmaI site. Two recombinant plasmids, with wild-type (pWT) and codon 61 mutant (pMUTX) inserts, were screened by XbaI digestion. pMUT2X, which contained a 2nd XbaI site (codon 35/ 36) was constructed by inverse PCR (Hemsley et al., 1989) of pMUTX with primers 2XBAF and 2XBAR (Figure 1) . The sequence of the insert in pWT is identical to H-ras in GenBank Accession No. U89950.
PCR ampli®cation of plasmid and genomic DNA EcoRI-digested skin chromosomal DNA (600 ng) or plasmid DNA (4 fg) was ampli®ed in a 20 ml reaction with 16PCR Buer (Epicentre), 1.5 mM MgCl 2 , 2.5 mM dNTPs, primers MRF and MRR, 1 ml [a-32 P]dCTP (6000 Ci/mmol) (Amersham), 5% formamide, 0.5 u Tth DNA polymerase, 0.06 u Vent DNA polymerase, covered with 15 ml mineral oil (Perkin-Elmer) and cycled at 948C, 1 min preheating followed by ®ve`cold' cycles of 948C, 15 s denaturation, 48C, 15 s annealing, 808C, 30 s extension, followed by 20`hot' cycles of 948C, 15 s denaturation, 558C, 15 s annealing, 808C, 30 s extension. For use in the sequencing experiments, primers MFPS and MRER which contained a PstI and an EcoRI site, respectively (Figure 1 ), were used without added radiolabel to amplify a PCR product that was digested with EcoRI and PstI and cloned into EcoRI-PstI sites of pUC18. The clones were sequenced with M13 universal primers in a model 373A sequencer (Applied Biosystems, CA).
RFLP analysis and detection sensitivity
The 32 P-labeled PCR products were puri®ed by phenol/ chloroform extraction and ethanol precipitation, digested with XbaI (Gibco ± BRL) and electrophoresed in a 20620 cm 3.5% 3 : 1 NuSieve Agarose (FMC, Rockland, ME) gel in 16 TAPE buer (40 mM Tris-Acetate, 1 mM EDTA, 1.12 mM Na-pyrophosphate, pH 8.0) for 525 volthours in a Model H4 gel (Gibco ± BRL). The gel was dried in a Model 583 gel drier (BioRad), exposed for 2 h to an intensifying screen and scanned by a PhosphorImager (Molecular Dynamics) to analyse the bands with 0.11 (low) to 10 000 (high) pixel limit settings. The pixel values were normalized for XbaI digestibility (d) which was determined from the control DNA mixtures. The typical XbaI digestibility was 92%, giving a d value of 1.08, determined as 1+1/100 (100 ± 92). The fraction of mutation (f MUT ) was expressed as d6MUT/ (WT+d6MUT), where MUT and WT were pixel counts of the appropriate bands. Mutation frequency (MF) values were determined from the standard curve ( Figure  5b ). To authenticate the 400 bp XbaI band as H-ras product, double digestion with XbaI and PleI in 16NEBuer 2 (New England Biolabs) was conducted in a duplicate gel.
